|
Demographics
|
|
Age, mean ± SD
|
67.65 ± 11.00
|
65.00 ± 12.30
|
0.33
|
|
Male, n (%)
|
13 (13.97)
|
6 (28.57)
|
0.11
|
|
Symptoms, n (%)
|
|
Dyspnoe
|
34 (36.55)
|
9 (42.85)
|
0.62
|
|
Chest pain
|
52 (55.91)
|
6 (28.57)
|
0.03
|
|
Clinic parameter
|
|
Systolic BP, mmHg
|
134.96 ± 28.41
|
116.25 ± 42.32
|
0.01
|
|
Diastolic BP, mmHg
|
78.41 ± 13.67
|
66.55 ± 31.22
|
0.03
|
|
Heart rate, bpm
|
98.17 ± 27.64
|
110.95 ± 22.79
|
0.05
|
|
ECG Data, n (%)
|
|
ST-segment elevation
|
27 (29.03)
|
7 (33.33)
|
0.79
|
|
Inversed T-Waves
|
83 (89.24)
|
19 (90.47)
|
0.74
|
|
PQ-interval
|
160.67 ± 27.97
|
160.00 ± 34.38
|
0.92
|
|
QTc (ms), mean ± SD
|
484.49 ± 50.83
|
455.30 ± 52.82
|
0.02
|
|
Stress factor, n (%)
|
|
Emotional sress
|
28 (30.10)
|
2 (9.52)
|
0.05
|
|
Physical stress
|
50 (53.76)
|
14 (66.66)
|
0.33
|
|
Laboratory values, mean ± SD
|
|
Troponin I (U/L)
|
3.20 ± 4.41
|
6.57 ± 8.46
|
0.01
|
|
Creatine phosphatkinase (U/L)
|
721.11 ± 2900.64
|
323.74 ± 469.71
|
0.55
|
|
CKMB
|
37.44 ± 65.08
|
31.00 ± 23.56
|
0.77
|
|
C-Reactive protein (mg/l)
|
42.63 ± 64.25
|
80.30 ± 126.15
|
0.06
|
|
Hemoglobin
|
12.10 ± 1.99
|
12.29 ± 2.08
|
0.70
|
|
Creatinine (mg/dl)
|
1.14 ± 0.76
|
1.19 ± 0.50
|
0.79
|
|
GFR < 60 ml/min
|
25 (26.88)
|
7 (33.33)
|
0.59
|
|
Echocardiography data, n (%)
|
|
LV EF %
|
39.67 ± 9.12
|
32.76 ± 9.09
|
< 0.01
|
|
Follow-up LV EF %
|
55.23 ± 7.54
|
48.63 ± 14.90
|
< 0.01
|
|
Apical ballooning
|
64 (68.81)
|
18 (85.71)
|
0.15
|
|
Mitral regurgation
|
50 (53.76)
|
10 (47.61)
|
0.63
|
|
Tricspid regurgation
|
42 (45.16)
|
7 (33.33)
|
0.46
|
|
RV-Involvement
|
17 (18.27)
|
9 (42.85)
|
0.02
|
|
Medical history, n (%)
|
|
Smoking
|
30 (32.25)
|
6 (28.57)
|
0.80
|
|
Diabetes mellitus
|
22 (23.65)
|
4 (19.04)
|
0.64
|
|
Obesity (BMI > 25 kg/m2)
|
27 (29.03)
|
4 (19.04)
|
0.75
|
|
Hypertension
|
54 (58.06)
|
12 (57.14)
|
1.00
|
|
COPD
|
19 (20.43)
|
7 (33.33)
|
0.25
|
|
Atrial fibrillation
|
15 (16.12)
|
6 (28.57)
|
0.21
|
|
Coronary artery disease
|
16 (17.20)
|
6 (28.57)
|
0.23
|
|
History of malignancy
|
13 (13.97)
|
3 (14.28)
|
0.97
|
|
Drugs on admission, n (%)
|
|
Beta-blocker
|
32 (34.40)
|
3 (14.28)
|
0.06
|
|
ACE inhibitor
|
30 (32.25)
|
5 (23.80)
|
0.45
|
|
ASS
|
24 (25.80)
|
5 (23.80)
|
0.87
|
|
Anticoagulation
|
7 (7.52)
|
0 (0)
|
0.19
|
